Update from the UK Pharmacy Professional Leadership Advisory Board – December 2024

Update from the UK Pharmacy Professional Leadership Advisory Board

The UK Pharmacy Professional Leadership Advisory Board met for the fourth time on 10 December 2024. Through the Board’s work, closer collaboration between pharmacy professional leadership bodies and specialist professional groups, supported by Independent Expert Members, will enable and support pharmacists and pharmacy technicians to meet the opportunities and challenges ahead.

Following another positive and productive meeting, the Board has published:

-A statement

-A blog post

-Minutes of the September 2024 meeting

-A draft Vision and Common Purpose for Pharmacy Professional Leadership (Also added to the BOPA website here: A Vision and Common Purpose for the future of UK Pharmacy Professional Leadership – BOPA


To read these and more information about the Board’s work, please visit Independent UK Pharmacy Professional Leadership Advisory Board to strengthen collaboration | Join the Conversation (scwcsu.nhs.uk).

You can also follow the Board on X: https://twitter.com/ukpplboard and on LinkedIn.  

Best regards.

UK Pharmacy Professional Leadership Advisory Board Secretariat

Email: [email protected]


A Vision and Common Purpose for the future of UK Pharmacy Professional Leadership – BOPA

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article